The European League Against Rheumatism is one of the most relevant congresses in the world of rheumatology. As a leading company in this field, IBSA will participate with a Satellite Symposium, co-sponsored with Bioiberica, and entirely dedicated to the highly purified, pharmaceutical-grade chondroitin sulfate; in particular, very interesting data from two very recent clinical studies (CONCEPT and MOSAIC studies) will be presented. See the full programme here.
All people interested in knowing more about IBSA as leading company in the field of OA and Pain, and about its pipeline of products (Condrosulf/chondroitin sulphate; Sinovial/i.a. HA; Flector/diclofenac epolamine; Akis-Dicloin/subcutaneous diclofenac) are also invited to visit us in the exhibition hall (stand #68, Exhibition Hall 10)